Advertisement

Sodium nitrate preconditioning prevents progression of the neuropathic pain in streptozotocin-induced diabetes Wistar rats

  • Hajar Oghbaei
  • Gisou Mohaddes
  • GholamReza Hamidian
  • Rana KeyhanmaneshEmail author
Research article
  • 2 Downloads

Abstract

Purpose

The purpose of the study was to evaluate the possible protective effects of low dose sodium nitrate preconditioning on the peripheral neuropathy in streptozotocin (STZ)-induced diabetic model.

Methods

Male Wistar rats were randomly divided into five groups: control (no intervention), control treated sodium nitrate (100 mg/L in drinking water), diabetic (no intervention), diabetic treated NPH insulin (2-4 U), and diabetic treated sodium nitrate (100 mg/L in drinking water). Diabetes was induced by intraperitoneal injection of STZ (60 mg/kg). All interventions were done for 60 days immediately following diabetes confirmation. Thermal and mechanical algesia thresholds were measured by means of hot-plate test, von Frey test, and tail-withdrawal test before the diabetic induction and after diabetes confirmation. At the end of the experiment, serum NOx level and serum insulin level were assessed. Blood glucose concentration and body weight have recorded at the base and duration of the experiment.

Results

Both hypoalgesia, hyperalgesia along with allodynia developed in diabetic rats. Significant alterations including, decrease in tail withdrawal latency (30th day), decreased mechanical threshold (60th day), and an increase in hot plate latency (61st day) were displayed in diabetic rats compared to control rats. Nitrate and insulin preconditioning produced protective effects against diabetes-induced peripheral neuropathy. Data analysis also showed a significant increase in glucose level as well as a considerable reduction in serum insulin and body weight of diabetic rats, which restored by both insulin and nitrate preconditioning.

Conclusion

Sodium nitrate preconditioning produces a protective effect in diabetic neuropathy, which may be mediated by its antihyperglycemic effects and increased serum insulin level.

Keywords

Nitrate preconditioning Diabetes Peripheral nerve Thermal algesia Mechanical algesia 

Notes

Acknowledgements

This article is a part of database from the investigation entitled “The effect of inorganic nitrate on the prevention and treatment of peripheral diabetic neuropathy in typ-1 diabetic male rats” written by Hajar Oghbaei, Faculty of Medicine, Tabriz University of Medical Sciences and was funded by the student research committee of Tabriz University of Medical Sciences (No. IR.TBZMED. REC.1395.960), Tabriz, Iran.

Compliance with ethical standards

Ethical issues

All of protocols were approved by the Ethics Committee of Animal Research of Tabriz University of Medical Sciences (No. IR.TBZMED.REC.1395.960).

Conflict of interests

Authors declare no conflict of interests.

References

  1. 1.
    Organization WH. Global report on diabetes. World Health Organization 2016. 2017.Google Scholar
  2. 2.
    Urbancic-Rovan V. Causes of diabetic foot lesions. Lancet. 2005;366(9498):1675–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978;1(3):168–88.CrossRefGoogle Scholar
  4. 4.
    Cermenati G, Abbiati F, Cermenati S, Brioschi E, Volonterio A, Cavaletti G, et al. Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation. J Lipid Res. 2012;53(2):300–10.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Vinik AI. Diabetic neuropathies. Controversies in treating diabetes. Springer 2008. p. 135–156.CrossRefGoogle Scholar
  6. 6.
    Rojas DR, Kuner R, Agarwal N. Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy. arXiv preprint arXiv:180306740 2018.Google Scholar
  7. 7.
    Han JW, Sin MY, Y-s Y. Cell therapy for diabetic neuropathy using adult stem or progenitor cells. Diabetes Metab J. 2013;37(2):91–105.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Nowicki M, Kosacka J, Serke H, Blüher M, Spanel-Borowski K. Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome. J Neurosci Res. 2012;90(1):122–31.PubMedCrossRefGoogle Scholar
  9. 9.
    Fioretto P, Dodson PM, Ziegler D, Rosenson RS. Residual microvascular risk in diabetes: unmet needs and future directions. Nat Rev Endocrinol. 2010;6(1):19–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Oates PJ. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol. 2002;50:325–92.PubMedCrossRefGoogle Scholar
  11. 11.
    Du X-L, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci. 2000;97(22):12222–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Eichberg J. Protein kinase C changes in diabetes: is the concept relevant to neuropathy? Int Rev Neurobiol. 2002;50:61–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Mišur I, Žarković K, Barada A, Batelja L, Miličević Z, Turk Z. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol. 2004;41(4):158–66.PubMedCrossRefGoogle Scholar
  14. 14.
    Miyauchi Y, Shikama H, Takasu T, Okamiya H, Umeda M, Hirasaki E, et al. Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats. Eur J Endocrinol. 1996;134(4):467–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the epidemiology of Diabetes Interventions, and Complications (EDIC) study. Diabetes Care. 2010.Google Scholar
  16. 16.
    Jin HY, Lee KA, Song SK, Liu WJ, Choi JH, Song CH, et al. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats. Eur J Pharmacol. 2012;674(2–3):217–26.PubMedCrossRefGoogle Scholar
  17. 17.
    Wang L, Chopp M, Szalad A, Lu X, Jia L, Lu M, et al. Tadalafil promotes the recovery of peripheral neuropathy in type II diabetic mice. PLoS One. 2016;11(7):e0159665.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Wang L, Chopp M, Szalad A, Jia L, Lu X, Lu M, et al. Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice. PLoS One. 2015;10(2):e0118134.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Gally JA, Montague PR, Reeke GN, Edelman GM. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci. 1990;87(9):3547–51.PubMedCrossRefGoogle Scholar
  20. 20.
    Moncada S, Higgs E. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147(S1):S193–201.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Garry P, Ezra M, Rowland M, Westbrook J, Pattinson K. The role of the nitric oxide pathway in brain injury and its treatment—from bench to bedside. Exp Neurol. 2015;263:235–43.PubMedCrossRefGoogle Scholar
  22. 22.
    Lundberg JO, Weitzberg E. NO-synthase independent NO generation in mammals. Biochem Biophys Res Commun. 2010;396(1):39–45.PubMedCrossRefGoogle Scholar
  23. 23.
    Muenzel T, Daiber A. Inorganic nitrite and nitrate in cardiovascular therapy: a better alternative to organic nitrates as nitric oxide donors? Vasc Pharmacol. 2018;102:1–10.CrossRefGoogle Scholar
  24. 24.
    Keyhanmanesh R, Hamidian G, Alipour MR, Oghbaei H. Benefiial treatment effects of dietary nitrate supplementation on testicular injury in streptozotocin-induced diabetic male rats. Reprod BioMed Online. 2019.Google Scholar
  25. 25.
    Lee-Kubli CA, Mixcoatl-Zecuatl T, Jolivalt CG, Calcutt NA. Animal models of diabetes-induced neuropathic pain. Behavioral Neurobiology of Chronic Pain. Springer 2014. p. 147-.Google Scholar
  26. 26.
    Oghbaei H, Asl NA, Sheikhzadeh F, Alipour MR. The effect of regular moderate exercise on miRNA-192 expression changes in kidney of streptozotocin-induced diabetic male rats. Adv Pharm Bull. 2015;5(1):127–32.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Oghbaei H, Asl NA, Sheikhzadeh F. Can regular moderate exercise lead to changes in miRNA-146a and its adapter proteins in the kidney of streptozotocin-induced diabetic male rats? Endocr Regul. 2017;51(3):145–52.PubMedCrossRefGoogle Scholar
  28. 28.
    Keyhanmanesh R, Hamidian G, Alipour MR, Ranjbar M, Oghbaei H. Protective effects of sodium nitrate against testicular apoptosis and spermatogenesis impairments in streptozotocin-induced diabetic male rats. Life Sci. 2018;211:63–73.PubMedCrossRefGoogle Scholar
  29. 29.
    Oghbaei H, Alipour MR, Hamidian G, Ahmadi M, Ghorbanzadeh V, Keyhanmanesh R. Two months sodium nitrate supplementation alleviates testicular injury in streptozotocin-induced diabetic male rats. Exp Physiol. 2018;103(12):1603–17.PubMedCrossRefGoogle Scholar
  30. 30.
    Oghbaei H, Alipour MR, Mohaddes G, Hamidian GR, Keyhanmanesh R. Evaluation of ameliorative effect of sodium nitrate in experimental model of streptozotocin-induced diabetic neuropathy in male rats. Endocr Regul. 2019;53(1):14–25.PubMedCrossRefGoogle Scholar
  31. 31.
    Dobson C, Tohyama Y, Diksic M, Hamel E. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia. 2004;24(1):2–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Kubo K, Nishikawa K, Ishizeki J, Hardy-Yamada M, Yanagawa Y, Saito S. Thermal hyperalgesia via supraspinal mechanisms in mice lacking glutamate decarboxylase 65. J Pharmacol Exp Ther. 2009;331(1):162–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Zeng P, Li S, Zheng Y-h, Liu F-Y, Wang J-l, Zhang D-l, et al. Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice. Peptides. 2014;55:103–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Oyenihi AB, Ayeleso AO, Mukwevho E, Masola B. Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int. 2015;2015.CrossRefGoogle Scholar
  35. 35.
    Grote CW, Wright DE. A role for insulin in diabetic neuropathy. Front Neurosci. 2016;10:581.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Cellek S. Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications. Curr Pharm Des. 2004;10(29):3683–95.PubMedCrossRefGoogle Scholar
  37. 37.
    Sasaki T, Yasuda H, Maeda K, Kikkawa R. Hyperalgesia and decreased neuronal nitric oxide synthase in diabetic rats. Neuroreport. 1998;9(2):177.CrossRefGoogle Scholar
  38. 38.
    Gheibi S, Jeddi S, Carlström M, Gholami H, Ghasemi A. Effects of long-term nitrate supplementation on carbohydrate metabolism, lipid profiles, oxidative stress, and inflammation in male obese type 2 diabetic rats. Nitric Oxide. 2018;75:27–41.PubMedCrossRefGoogle Scholar
  39. 39.
    Nyström T, Ortsäter H, Huang Z, Zhang F, Larsen FJ, Weitzberg E, et al. Inorganic nitrite stimulates pancreatic islet blood flow and insulin secretion. Free Radic Biol Med. 2012;53(5):1017–23.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Henstridge DC, Duffy SJ, Formosa MF, Ahimastos AA, Thompson BR, Kingwell BA. Oral nitrate therapy does not affect glucose metabolism in healthy men. Clin Exp Pharmacol Physiol. 2009;36(11):1086–92.PubMedCrossRefGoogle Scholar
  41. 41.
    Bahadoran Z, Ghasemi A, Mirmiran P, Azizi F, Hadaegh F. Beneficial effects of inorganic nitrate/nitrite in type 2 diabetes and its complications. Nutr Metab. 2015;12(1):16.CrossRefGoogle Scholar
  42. 42.
    Gheibi SBF, Jeddi S, Farrokhfall K, Zardooz H, Ghasemi A. Nitrite increases glucose-stimulated insulin secretion and islet insulin content in obese type 2 diabetic male rats. Nitric Oxide. 2017;1(64):39–51.CrossRefGoogle Scholar
  43. 43.
    Varzandi T, Abdollahifar MA, Rohani SAH, Piryaei A, Zadeh-Vakili A, Jeddi S, et al. Effect of long-term nitrite administration on browning of white adipose tissue in type 2 diabetic rats: a stereological study. Life Sci. 2018;207:219–26.PubMedCrossRefGoogle Scholar
  44. 44.
    Henstridge D, Kingwell BA, Formosa MF, Drew B, McConell GK, Duffy S. Effects of the nitric oxide donor, sodium nitroprusside, on resting leg glucose uptake in patients with type 2 diabetes. Diabetologia. 2005;48(12):2602–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Gilchrist M, Winyard PG, Aizawa K, Anning C, Shore A, Benjamin N. Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic Biol Med. 2013;60:89–97.PubMedCrossRefGoogle Scholar
  46. 46.
    Kobayashi J. Nitric oxide and insulin resistance. Immunoendocrinology. 2015;2.Google Scholar
  47. 47.
    Ogur R, Coskun O, Korkmaz A, Oter S, Yaren H, Hasde M. High nitrate intake impairs liver functions and morphology in rats; protective effects of α-tocopherol. Environ Toxicol Pharmacol. 2005;20(1):161–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Chaoui A, Zaki A, Talibi A, Chait A, Derouiche A, Aboussaouira T, et al. Effects of inorganic nitrates on thyroid gland activity and morphology in female rats. Therapie. 2004;59(4):471–5.PubMedCrossRefGoogle Scholar
  49. 49.
    Seethalakshmi L, Menon M, Diamond D. The effect of streptozotocin-induced diabetes on the neuroendocrine-male reproductive tract axis of the adult rat. J Urol. 1987;138(1):190–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Assmann TS, Brondani LA, Boucas AP, Rheinheimer J, de Souza BM, Canani LH, et al. Nitric oxide levels in patients with diabetes mellitus: a systematic review and meta-analysis. Nitric Oxide. 2016;61:1–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Schmetterer L, Findl O, Fasching P, Ferber W, Strenn K, Breiteneder H, et al. Nitric oxide and ocular blood flow in patients with IDDM. Diabetes. 1997;46(4):653–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, et al. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol. 2005;1(5):290–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Ashmore T, Roberts LD, Morash AJ, Kotwica AO, Finnerty J, West JA, et al. Nitrate enhances skeletal muscle fatty acid oxidation via a nitric oxide-cGMP-PPAR-mediated mechanism. BMC Biol. 2015;13(1):110.PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Barrot M. Tests and models of nociception and pain in rodents. Neuroscience. 2012;211:39–50.PubMedCrossRefGoogle Scholar
  55. 55.
    Khan G, Chen S-R, Pan H-L. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience. 2002;114(2):291–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Shir Y, Seltzer ZE. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett. 1990;115(1):62–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Wang X-L, Zhang Q, Zhang Y-Z, Liu Y-T, Dong R, Wang Q-J, et al. Downregulation of GABAB receptors in the spinal cord dorsal horn in diabetic neuropathy. Neurosci Lett. 2011;490(2):112–5.PubMedCrossRefGoogle Scholar
  58. 58.
    Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol. 2002;50:205–28.PubMedCrossRefGoogle Scholar
  59. 59.
    Gong Y-H, Yu X-R, Liu H-L, Yang N, Zuo P-P, Huang Y-G. Antinociceptive effects of combination of tramadol and acetaminophen on painful diabetic neuropathy in streptozotocin-induced diabetic rats. Acta Anaesthesiol Taiwanica. 2011;49(1):16–20.CrossRefGoogle Scholar
  60. 60.
    Yagihashi S, Mizukami H. Diabetic Neuropathy. Diabetes and aging-related complications: Springer; 2018. p. 31–43.Google Scholar
  61. 61.
    Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain. 1996;68(2–3):293–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Gilliatt R, Willison R. Peripheral nerve conduction in diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1962;25(1):11.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Prnova MS, Svik K, Bezek S, Kovacikova L, Karasu C, Stefek M. 3-Mercapto-5H-1, 2, 4-Triazino [5, 6-b] Indole-5-acetic acid (Cemtirestat) alleviates symptoms of peripheral diabetic neuropathy in Zucker diabetic fatty (ZDF) rats: a role of aldose reductase. Neurochem Res. 2019:1–9.Google Scholar
  64. 64.
    Chen Y-W, Hsieh P-L, Chen Y-C, Hung C-H, Cheng J-T. Physical exercise induces excess hsp72 expression and delays the development of hyperalgesia and allodynia in painful diabetic neuropathy rats. Anesth Analg. 2013;116(2):482–90.PubMedCrossRefGoogle Scholar
  65. 65.
    Ismail CAN, Aziz CBA, Suppian R, Long I. Imbalanced oxidative stress and pro-inflammatory markers differentiate the development of diabetic neuropathy variants in streptozotocin-induced diabetic rats. J Diabetes Metab Disord. 2018;1.Google Scholar
  66. 66.
    Brussee V, Cunningham FA, Zochodne DW. Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes. 2004;53(7):1824–30.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Student Research CommitteeTabriz University of Medical SciencesTabrizIran
  2. 2.Neurosciences Research CenterTabriz University of Medical SciencesTabrizIran
  3. 3.Department of Basic Sciences, Faculty of Veterinary MedicineUniversity of TabrizTabrizIran
  4. 4.Tuberculosis and Lung Diseases Research CenterTabriz University of Medical SciencesTabrizIran
  5. 5.Department of Physiology, Faculty of MedicineTabriz University of Medical SciencesTabrizIran
  6. 6.Neurogenic Inflammation Research CenterMashhad University of Medical SciencesMashhadIran

Personalised recommendations